IPF
Clinical trials for IPF explained in plain language.
Never miss a new study
Get alerted when new IPF trials appear
Sign up with your email to follow new studies for IPF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to slow lung scarring in IPF patients
Disease control Recruiting nowThis study tests an experimental drug called SB17170 in 30 adults aged 40 and older with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and breathing problems. Participants will receive either the drug or a placebo for 12 weeks. The main goal is to see i…
Matched conditions: IPF
Phase: PHASE2 • Sponsor: SPARK Biopharma • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New inhaled therapy for scarred lungs enters first human tests
Disease control Recruiting nowThis early-stage study tests an inhaled drug called AGMB-447 in healthy volunteers and people with idiopathic pulmonary fibrosis (IPF), a lung-scarring disease. The main goal is to see if the drug is safe and how the body processes it. About 145 participants will receive either t…
Matched conditions: IPF
Phase: PHASE1 • Sponsor: Agomab Spain S.L. • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Can virtual exercise help lung scarring patients breathe easier?
Symptom relief Recruiting nowThis study tests two types of home exercise programs for people with idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring and shortness of breath. Participants will be split into two groups: one doing live online exercise sessions and the other following video…
Matched conditions: IPF
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
New drug candidate takes first step toward lung disease treatment
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called HW241045 in 56 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose and are monitored for side effects. This is a necessary first step before testing the drug in people with a lung con…
Matched conditions: IPF
Phase: PHASE1 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 07:27 UTC
-
Can a simple breath test predict lung scarring? new study aims to find out
Knowledge-focused Recruiting nowThis observational study aims to find early warning signs (biomarkers) that can predict when lung scarring (fibrosis) will get worse in people with various interstitial lung diseases. Researchers will follow 450 adults with conditions like idiopathic pulmonary fibrosis (IPF) or o…
Matched conditions: IPF
Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC